Literature DB >> 15933803

Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan.

Yasutsugu Chinen1, Takaya Tohma2, Yoshinori Izumikawa2, Hiroyuki Uehara2, Takao Ohta2.   

Abstract

Sanfilippo type B syndrome (mucopolysaccharidosis type IIIB; MPS IIIB) is an autosomal recessive lysosomal storage disorder that is caused by defective alpha- N-acetylglucosaminidase (NAGLU). We performed NAGLU gene analysis in five patients with MPS IIIB whose respective parents from the Okinawa islands in Japan were not apparently consanguineous. We found a missense mutation (R565P) in all five patients (all homozygotes). We screened this mutation in 200 healthy subjects and found one heterozygote (none of the subjects were related to the patients). These results suggest that there may be a founder effect that results in the accumulation of R565P mutation in this area.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933803     DOI: 10.1007/s10038-005-0258-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  The molecular basis of Sanfilippo syndrome type B.

Authors:  H G Zhao; H H Li; G Bach; A Schmidtchen; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 2.  Enzymic diagnosis of the genetic mucopolysaccharide storage disorders.

Authors:  C W Hall; I Liebaers; P Di Natale; E F Neufeld
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes.

Authors:  B Weber; X H Guo; W J Kleijer; J J van de Kamp; B J Poorthuis; J J Hopwood
Journal:  Eur J Hum Genet       Date:  1999-01       Impact factor: 4.246

4.  Incidence of the mucopolysaccharidoses in Northern Ireland.

Authors:  J Nelson
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

5.  NAGLU mutations underlying Sanfilippo syndrome type B.

Authors:  A Schmidtchen; D Greenberg; H G Zhao; H H Li; Y Huang; P Tieu; H Z Zhao; S Cheng; Z Zhao; C B Whitley; P Di Natale; E F Neufeld
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

6.  Molecular analysis of the alpha-N-acetylglucosaminidase gene in seven Japanese patients from six unrelated families with mucopolysaccharidosis IIIB (Sanfilippo type B), including two novel mutations.

Authors:  Akemi Tanaka; Masatsugu Kimura; Hoàng Thi Ngoc Lan; Natsuko Takaura; Tunekazu Yamano
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

7.  Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).

Authors:  C E Beesley; E P Young; A Vellodi; B G Winchester
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

8.  Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C).

Authors:  J J van de Kamp; M F Niermeijer; K von Figura; M A Giesberts
Journal:  Clin Genet       Date:  1981-08       Impact factor: 4.438

9.  Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel alpha-N-acetylglucosaminidase gene mutations.

Authors:  S Bunge; A Knigge; C Steglich; W J Kleijer; O P van Diggelen; M Beck; A Gal
Journal:  J Med Genet       Date:  1999-01       Impact factor: 6.318

10.  Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients.

Authors:  A Tessitore; G R Villani; C Di Domenico; M Filocamo; R Gatti; P Di Natale
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

View more
  8 in total

1.  Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.

Authors:  Daniel Ysselstein; Joshua M Shulman; Dimitri Krainc
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

2.  Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.

Authors:  Min-Sun Kim; Aram Yang; Eu-Seon Noh; Chiwoo Kim; Ga Young Bae; Han Hyuk Lim; Hyung-Doo Park; Sung Yoon Cho; Dong-Kyu Jin
Journal:  J Pers Med       Date:  2022-04-21

3.  Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.

Authors:  Tsutomu Shimada; Joan Kelly; William A LaMarr; Naomi van Vlies; Eriko Yasuda; Robert W Mason; William Mackenzie; Francyne Kubaski; Roberto Giugliani; Yasutsugu Chinen; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji E Orii; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2014-07-21       Impact factor: 4.797

4.  Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.

Authors:  Marlies J Valstar; Hennie T Bruggenwirth; Renske Olmer; Ron A Wevers; Frans W Verheijen; Ben J Poorthuis; Dicky J Halley; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

Review 5.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

6.  "Genotype-first" approaches on a curious case of idiopathic progressive cognitive decline.

Authors:  Lingling Shi; Bingxiao Li; Yonglan Huang; Xueying Ling; Tianyun Liu; Gholson J Lyon; Anding Xu; Kai Wang
Journal:  BMC Med Genomics       Date:  2014-12-03       Impact factor: 3.063

7.  Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB.

Authors:  O L M Meijer; L Welling; M J Valstar; L H Hoefsloot; H T Brüggenwirth; A T van der Ploeg; G J G Ruijter; T Wagemans; F A Wijburg; N van Vlies
Journal:  J Inherit Metab Dis       Date:  2016-02-23       Impact factor: 4.982

8.  Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities.

Authors:  Yana Puckett; Alejandra Mallorga-Hernández; Adriana M Montaño
Journal:  Orphanet J Rare Dis       Date:  2021-05-29       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.